alexa Kymberly Harrington
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kymberly Harrington

Dr. Kymberly Harrington
University of Illinois at Rockford
Department of Biomedical Sciences

Dr. Kymberly Harrington working as assistant professor in University of Illinois at Rockford, Department of Biomedical Sciences, USA. Dr. Kymberly Harrington has 13 over peer reviewed publications. Dr. Kymberly Harrington has research interest in Cancer Research.

Research Interest

Dr. Kymberly Harrington has research interest in Cancer Research.


EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer

Amanda Stone, Kymberly Harrington, Mark Frakes, Kory Blank, Supriya Rajanna, Ichwaku Rastogi and Neelu Puri

Review Article: J Carcinog & Mutagen 2014, 5: 173

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version